in vitro News and Research

RSS

GNA Biosolutions launches world’s first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

From HP Health Solutions Germany GmbH 20 Apr 2018

Two MDC researchers win ERC funding worth several million euros

Basic researchers Gary Lewin and Norbert Hübner are investigating the molecular mechanisms underlying neurological and heart diseases. Their focus is on understanding the anchoring of ion channels and micropeptides in heart muscle cells.

13 Apr 2018

Glucose metabolism is key to neural network development, finds study

A new study has found that glucose metabolism is critical for the development of neural networks in the brain.

13 Apr 2018

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.

12 Apr 2018

CReM researchers optimize process to engineer disease- or patient-specific lung stem cells

The Center for Regenerative Medicine at Boston University and Boston Medical Center has engineered two new categories of lung epithelial cells in vitro using pluripotent stem cells.

12 Apr 2018

Lithuanian researchers use freeze-drying technique to create sponge-like wound dressings

Group of researchers at Kaunas University of Technology, Lithuania are developing new generation sponge-like wound dressings with hyaluronic acid. Antimicrobial, antioxidant, anti-inflammatory wound dressings stimulate tissue regeneration and can be especially efficient in treating deep wounds that are difficult to heal.

12 Apr 2018

TradeShow Talks with Cyanagen

We are Cyanagen, an Italian company, here at Analytica in hall A3 booth 416. We produce reagents for molecular biology, mainly ECL substrates for Western blot analyzers and fluorescent reagents for several applications.

From Cyanagen Srl 12 Apr 2018

Tradeshow Talks with POREX

News Medical talk to POREX to find out why they are exhibiting at analytica 2018.

From Porex Corporation 11 Apr 2018

Miniature injectable biosensor could offer continuous, long-term alcohol monitoring

Engineers at the University of California San Diego have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring.

11 Apr 2018

Oxford Gene Technology announces leadership changes

Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.

From Oxford Gene Technology 10 Apr 2018

Food packaging may have negative impact on nutrient absorption in the intestine

Food packaging could be negatively affecting the way in which your digestive tract operates, according to new research by faculty and students at Binghamton University, State University at New York.

9 Apr 2018

Experts explore how degenerative processes impair the body's detoxification system

A poor diet and other risk factors can result in liver disease. This important metabolic organ can become fatty and inflamed. In the long term, this may result in irreversible and life-threatening organ damage (cirrhosis of the liver or 'shrunken liver').

9 Apr 2018

Nano-photothermal neural stimulation method for patients with neurological disorders

A KAIST team presented a highly customizable neural stimulation method. The research team developed a technology that can print the heat pattern on a micron scale to enable the control of biological activities remotely.

6 Apr 2018

Researchers discover potential new therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer in children and adolescents, and a tumor known by its aggressiveness and tendency to metastasize.

5 Apr 2018

Porex to display innovations in laboratory liquid handling, diagnostics and chromatography at Analytica 2018

At next month’s Analytica event, Porex Corporation will display new solutions for laboratory and medical professionals that improve accuracy and purity in liquid handling, speed fluid transfer of diagnostics and optimize chromatography operations.

From Porex Corporation 31 Mar 2018

FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system

The U.S. Food and Drug Administration today permitted marketing of the Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes.

28 Mar 2018

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

Each day, normal human cell tissues express a protein known as p53 that wages war against potential malignancies. However, between 30 and 40 percent of human breast cancers express a defective (mutant) form of p53 that helps cancer cells proliferate and grow.

27 Mar 2018

Scientists create synthesized antibiotic capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time -- and could lead to the first new class of antibiotic drug in 30 years.

23 Mar 2018

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Neem Biotech, a Wales-based R&D biotech working in the field of novel antimicrobial drug development, announced today that it will be presenting results of its ongoing development work into the impact of NX-AS-401, its lead candidate,on biofilms in chronic cystic fibrosis lung infections at the 15th European Cystic Fibrosis Basic Science Conference taking place from 21st to 24th March 2018 in LoutrakiKorinthias, Greece.

From Neem Biotech 22 Mar 2018

Targeting aberrantly active telomerase to treat therapy-resistant melanoma

A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma.

21 Mar 2018

in vitro News and Research

GNA Biosolutions launches world’s first Laser PCR platform at Medica Trade Fair

Two MDC researchers win ERC funding worth several million euros

Glucose metabolism is key to neural network development, finds study

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

CReM researchers optimize process to engineer disease- or patient-specific lung stem cells

Lithuanian researchers use freeze-drying technique to create sponge-like wound dressings

TradeShow Talks with Cyanagen

Tradeshow Talks with POREX

Miniature injectable biosensor could offer continuous, long-term alcohol monitoring

Oxford Gene Technology announces leadership changes

Food packaging may have negative impact on nutrient absorption in the intestine

Experts explore how degenerative processes impair the body's detoxification system

Nano-photothermal neural stimulation method for patients with neurological disorders

Researchers discover potential new therapeutic target for Ewing sarcoma

Porex to display innovations in laboratory liquid handling, diagnostics and chromatography at Analytica 2018

FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

Scientists create synthesized antibiotic capable of treating superbugs

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Targeting aberrantly active telomerase to treat therapy-resistant melanoma

Driving innovation in drug discovery with in vitro biology solutions eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News